Performance analysis of Decibel Therapeutics (DBTX)
Annual Return
Over the past 3 years, DBTX has had an average annual return of +17.17%, outperforming the benchmark SPY, which returned +1.94% annual.
Over the past 5 years, DBTX has had an average annual return of -21.73%, underperforming the benchmark SPY, which returned +2.68% annual.
Since Feb 12, 2021, DBTX has had an average annual return of -39.18%, underperforming the benchmark SPY, which returned +5.36% annual.
| 2023 | 2022 | 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +139.49% | -55.91% | -74.21% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +54.18% | +35.42% | -29.44% | +6.63% | +25.48% | -4.73% | -22.06% | +68.63% | -2.96% | +139.49% | |||
| 2022 | -7.52% | -18.62% | -13.14% | -33.87% | +9.42% | +91.39% | +9.51% | +7.16% | -29.96% | +6.93% | -17.01% | -33.24% | -55.91% |
| 2021 | +4.16% | -39.51% | -19.73% | -1.86% | -3.91% | -16.98% | +13.03% | -4.47% | +5.19% | -14.92% | -32.61% | -74.21% |
Drawdown analysis of Decibel Therapeutics (DBTX)
The maximum drawdown for the DBTX was -90.70%, occurring on May 9, 2022. This drawdown has not yet recovered.
The current DBTX drawdown is -75.33%.
Since Feb 12, 2021 DBTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.70% | Feb 22, 2021 | 306 | May 9, 2022 | Ongoing | Ongoing | Ongoing |